Approval of Waiver on Government Site Condition for Bristol Myers Cardiac Drug Mavacamten Trial: CDSCO Panel Dr. Divya Colin10 Sept 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by Bristol-Myers, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
US FDA calls for USFDA boxed warning changes on CAR-T cancer therapies Kajal Rajput19 April 2024 1:32 PM ISTLondon: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called...
Bristol Myers sues AstraZeneca over cancer-treatment patents MD Bureau19 March 2022 6:08 PM ISTBristol asked the Delaware court for an undisclosed amount of monetary damages.
Delhi HC restrains Micro Lab from infringing Bristol Myers anticoagulant drug Apixaban Medical Dialogues Team19 Aug 2021 5:07 PM ISTNew Delhi: The Delhi High Court has passed an ex-parte ad- interim injunction restraining Micro Labs Limited from infringing any generic Apixaban...
Bristol Myers' Opdivo with Exelixis drug cuts kidney cancer death risk - study Medical Dialogues Team21 Sept 2020 12:45 PM ISTNEW YORK: Bristol Myers Squibb Co's cancer immunotherapy Opdivo in combination with Exelixis Inc's Cabometyx reduced the risk of death by 40% in...
Bristol Myers Squibb Onureg gets USFDA approval to treat Acute Myeloid Leukemia Medical Dialogues Bureau12 Sept 2020 9:15 AM ISTPrinceton: Bristol Myers Squibb recently announced that the U.S. Food and Drug Administration (FDA) has approved Onureg (azacitidine 300 mg tablets,...
GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 mln savita thakur thakur19 Dec 2015 1:05 PM ISTLondon: Pharmaceutical group GlaxoSmithKline said its majority-owned HIV drugs business would buy drugs at different stages of development from U.S....
FDA declines expanded approval for Bristol-Myers' Opdivo drug Pooja Bhatia Bhatia28 Nov 2015 9:56 AM ISTBristol-Myers Squibb Co said the U.S. Food and Drug Administration declined to approve its immuno-oncology drug, Opdivo, for its expanded use to treat...
FDA approves Bristol-Myers immunotherapy drug Opdivo Pooja Bhatia Bhatia11 Oct 2015 11:30 AM ISTBristol-Myers Squibb Co’s immunotherapy drug Opdivo has received the green signal from USFDA to treat an advanced form of lung cancer.The agency said...
Bristol-Myers combination drugs for cancer approved Meghna A Singhania3 Oct 2015 12:56 PM ISTBristol-Myers Squibb Co has got an early approval on its combination of breakthrough drugs to boost the immune system to fight cancer. This...
